Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1951 4
1952 3
1953 3
1954 1
1955 4
1956 3
1957 2
1958 4
1959 1
1966 1
1967 4
1969 2
1970 4
1971 2
1973 4
1974 4
1975 1
1976 3
1978 2
1979 3
1980 1
1981 3
1982 3
1983 2
1984 1
1985 6
1986 3
1987 1
1988 1
1989 3
1990 2
1991 1
1992 1
1993 3
1994 6
1995 8
1996 7
1997 9
1998 15
1999 11
2000 17
2001 13
2002 5
2003 1
2005 2
2006 2
2007 2
2008 5
2009 8
2010 7
2011 2
2012 1
2013 7
2014 6
2015 9
2016 7
2017 13
2018 5
2019 10
2020 11
2021 6
2022 10
2023 4
2024 13
2025 10
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

304 results

Results by year

Filters applied: . Clear all
Page 1
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection.
Mayer KA, Schrezenmeier E, Diebold M, Halloran PF, Schatzl M, Schranz S, Haindl S, Kasbohm S, Kainz A, Eskandary F, Doberer K, Patel UD, Dudani JS, Regele H, Kozakowski N, Kläger J, Boxhammer R, Amann K, Puchhammer-Stöckl E, Vietzen H, Beck J, Schütz E, Akifova A, Firbas C, Gilbert HN, Osmanodja B, Halleck F, Jilma B, Budde K, Böhmig GA. Mayer KA, et al. Among authors: schutz e. N Engl J Med. 2024 Jul 11;391(2):122-132. doi: 10.1056/NEJMoa2400763. Epub 2024 May 25. N Engl J Med. 2024. PMID: 38804514 Clinical Trial.
Toxicology of clobazam.
Schütz E. Schütz E. Br J Clin Pharmacol. 1979;7 Suppl 1(Suppl 1):33S-35S. doi: 10.1111/j.1365-2125.1979.tb04662.x. Br J Clin Pharmacol. 1979. PMID: 35202 Free PMC article.
Cachexia in liver cirrhosis.
Plauth M, Schütz ET. Plauth M, et al. Among authors: schutz et. Int J Cardiol. 2002 Sep;85(1):83-7. doi: 10.1016/s0167-5273(02)00236-x. Int J Cardiol. 2002. PMID: 12163212 Review.
Donor-derived cell-free DNA monitoring for early diagnosis of antibody-mediated rejection after kidney transplantation: a randomized trial.
Akifova A, Budde K, Amann K, Buettner-Herold M, Choi M, Oellerich M, Beck J, Bornemann-Kolatzki K, Schütz E, Bachmann F, Halleck F, von Hoerschelmann E, Koch N, Schrezenmeier E, Seelow E, Waiser J, Zukunft B, Eckardt KU, Halbritter J, Kettritz R, Del Moral CL, Lachmann N, Stauch D, Niemann M, Schmidt D, Halloran PF, Osmanodja B. Akifova A, et al. Among authors: schutz e. Nephrol Dial Transplant. 2025 Jun 30;40(7):1384-1395. doi: 10.1093/ndt/gfae282. Nephrol Dial Transplant. 2025. PMID: 39673311 Free PMC article. Clinical Trial.
Emphysematous pyelonephritis caused by C. glabrata.
Schutz EA, Zabott AP, Boaretto RBB, Toyama G, Morais CF, Moroni JG, Oliveira CS. Schutz EA, et al. J Bras Nefrol. 2022 Jul-Sep;44(3):447-451. doi: 10.1590/2175-8239-JBN-2020-0184. J Bras Nefrol. 2022. PMID: 33760910 Free PMC article.
Donor-derived cell-free DNA as a diagnostic tool in transplantation.
Oellerich M, Budde K, Osmanodja B, Bornemann-Kolatzki K, Beck J, Schütz E, Walson PD. Oellerich M, et al. Among authors: schutz e. Front Genet. 2022 Oct 21;13:1031894. doi: 10.3389/fgene.2022.1031894. eCollection 2022. Front Genet. 2022. PMID: 36339004 Free PMC article. Review.
Using circulating cell-free DNA to monitor personalized cancer therapy.
Oellerich M, Schütz E, Beck J, Kanzow P, Plowman PN, Weiss GJ, Walson PD. Oellerich M, et al. Among authors: schutz e. Crit Rev Clin Lab Sci. 2017 May;54(3):205-218. doi: 10.1080/10408363.2017.1299683. Epub 2017 Apr 10. Crit Rev Clin Lab Sci. 2017. PMID: 28393575 Review.
304 results